New AI-generated COVID drug enters Phase I clinical trials: Claims to be effective against all variants

Insilico Medicine, an AI-driven biotech company, has announced its AI-designed COVID-19 drug is entering Phase I clinical trials. Promising to deliver lasting results against all variants, this could become the first viable alternative to Paxlovid.

To stay on top of such cutting-edge advancements in AI, [look here first.](https://supercharged-ai.beehiiv.com/subscribe?utm_source=reddit&utm_medium=insilico-covid-drug&utm_campaign=campaign)

**Insilico's breakthrough medicine, ISM3312**

* Generated using Artificial Intelligence, ISM3312 may offer the superior solution to the constraints of current oral medication, Paxlovid.
* Insilico’s new drug could address the limitations of …

artificial artificial intelligence become biotech clinical clinical trials covid covid-19 generated insilico medicine intelligence medicine variants